Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

stanley_crooke

Ionis founder Stanley T Crooke to retire

December 18, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Ionis Pharmaceuticals has announced that its founder, Dr Stanley T Crooke, will retire from the company and its board of …
Appointment
barry-green-headshot

Sage Therapeutics appoints Barry Greene as CEO

December 18, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Sage Therapeutics, a biopharmaceutical company focused on developing treatments for central nervous system disorders, has appointed Barry Greene as Chief …
Appointment
top10

Top Ten most popular articles on Pharmafile.com this week

December 18, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Vaccine, antibody

The top news stories of the past week continue to centre around the COVID-19 pandemic; a new variant of the …
News
1_1

Samsung Biologics names John Rim as CEO and President

December 17, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Samsung BioLogics

Samsung Biologics has appointed John Rim as the company’s President and CEO. The appointment was made effective immediately and formalised via the …
Appointment
nice_new_london_office_internal_3_web

NICE recommends Novartis’ Beovu for wet age-related macular degeneration

December 16, 2020 Research and Development NICE, Novartis, wet AMD Beovu

NICE has published its final appraisal of Novartis’ Beovu (brolucizumab), recommending that the drug be made available via the NHS …
News

Quarter of the world may not access COVID-19 vaccine until 2022

December 16, 2020 Research and Development COVID-19, Vaccine

Almost a quarter of the world’s population may not have access to a COVID-19 vaccine until 2022, according to a …
News
abbvie_0

AbbVie buys COVID-19 antibody licence from Harbour BioMed

December 16, 2020 Research and Development AbbVie, COVID-19, Harbour BioMed, antibody

Harbour BioMed (HBM) and Utrecht University (UU) have announced that their fully human, SARS-CoV-2 neutralising antibody 47D11 and programme, has …
News
dw-anzcxqaqavhl

FDA panel backs Novartis’ Entresto for different form of heart disease

December 16, 2020 Research and Development FDA, Novartis, heart failure

Novartis’ heart failure drug Entresto has received recommendation from the FDA’s Cardiovascular and Renal Drugs Advisory Committee for use in …
News
lilly_building_with_american_flag_web

Eli Lilly scoops up gene therapy specialist Prevail Therapeutics for a potential $1.04bn

December 16, 2020 Research and Development, Sales and Marketing Eli Lilly, Prevail, acquisition

Eli Lilly has struck a deal to acquire Prevail Therapeutics in a transaction that could be valued at up to …
News

How COVID-19 is affecting diabetics and their access to insulin in America

December 15, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Diabetic patients face daily challenges of treatment access and treatment management, so 2020 has been a particularly challenging year. Conor …
Feature
3500

UAE rolls out Sinopharm COVID-19 vaccine amid conflicting reports of efficacy

December 15, 2020 Manufacturing and Production, Research and Development COVID-19, China, Sinopharm, UAE, coronavirus

The United Arab Emirates has begun rolling out Sinopharm’s COVID-19 vaccine in its capital Abu Dhabi, despite claims that numerous …
News
reuters_-_tatyana_makeyeva_1

Final control point analysis shows 90% efficacy for Russia’s Sputnik V COVID-19 vaccine

December 15, 2020 Manufacturing and Production, Research and Development COVID-19, Sputnik V, Vaccine

Efficacy data have been revealed from the final control point data analysis for Russia’s Sputnik V COVID-19 vaccine, showing the …
News
1920px-city_of_london_skyline_from_london_city_hall_-_sept_2015_-_crop

New coronavirus strain identified in the UK

December 15, 2020 Manufacturing and Production, Research and Development COVID-19, UK, coronavirus, vaccines

A new variant of coronavirus has been identified in the UK, and is growing faster in some parts of England, …
News
image_3

PPAs – Ready to make a long-term commitment to zero carbon?

December 14, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Energy, sustainability

As an industry that consumes a large amount of energy, the pressure is on for the pharmaceutical sector to achieve …
News

PPAs – Ready to make a long-term commitment to zero carbon?

December 14, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Energy, sustainability

As an industry that consumes a large amount of energy, the pressure is on for the pharmaceutical sector to achieve …
News
Press release
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026